eBioMedicine General Biochemistry, Genetics and Molecular Biology
Feasibility of single-dose neoadjuvant pembrolizumab with subablative radiotherapy in operable breast cancer: a single-centre phase 1b/2 window-of-opportunity trial
The publisher did not provide an abstract — full text is available via the link below.